JP2023538807A5 - - Google Patents
Info
- Publication number
- JP2023538807A5 JP2023538807A5 JP2023502703A JP2023502703A JP2023538807A5 JP 2023538807 A5 JP2023538807 A5 JP 2023538807A5 JP 2023502703 A JP2023502703 A JP 2023502703A JP 2023502703 A JP2023502703 A JP 2023502703A JP 2023538807 A5 JP2023538807 A5 JP 2023538807A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- sar
- compstatin analog
- acceptable salt
- peg3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20186297 | 2020-07-16 | ||
| EP20186297.6 | 2020-07-16 | ||
| PCT/EP2021/069798 WO2022013374A1 (en) | 2020-07-16 | 2021-07-15 | Inhibitors of complement factor c3 and their medical uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538807A JP2023538807A (ja) | 2023-09-12 |
| JP2023538807A5 true JP2023538807A5 (https=) | 2024-07-24 |
Family
ID=71661768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502703A Pending JP2023538807A (ja) | 2020-07-16 | 2021-07-15 | 補体因子ｃ３の阻害剤及びそれらの医学的使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230287051A1 (https=) |
| EP (1) | EP4182023A1 (https=) |
| JP (1) | JP2023538807A (https=) |
| KR (1) | KR20230039718A (https=) |
| CN (1) | CN116209671A (https=) |
| AU (1) | AU2021309548A1 (https=) |
| CA (1) | CA3185730A1 (https=) |
| CO (1) | CO2023001411A2 (https=) |
| IL (1) | IL299870A (https=) |
| MX (1) | MX2023000679A (https=) |
| WO (1) | WO2022013374A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2020128624A (ru) | 2018-02-27 | 2022-03-28 | Зп Спв 3 К/С | Аналоги компстатина и их медицинское применение |
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
| CN120359233A (zh) * | 2022-11-24 | 2025-07-22 | 阿麦达斯制药美国有限责任公司 | 用于基于载体的疗法的坎普他汀类似物 |
| CN118812653A (zh) * | 2023-04-18 | 2024-10-22 | 成都奥达生物科技有限公司 | 一种长效坎普他汀化合物 |
| CN119219741A (zh) * | 2023-06-29 | 2024-12-31 | 刘晓蓉 | 新型补体抑制剂及其制备、应用和产品 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6319897B1 (en) | 1996-03-13 | 2001-11-20 | John D. Lambris | Peptides which inhibit complement activation |
| AU723268B2 (en) | 1996-09-09 | 2000-08-24 | Zealand Pharma A/S | Improved solid-phase peptide synthesis and agent for use in such synthesis |
| WO1999013899A1 (en) | 1997-09-17 | 1999-03-25 | Trustees Of The University Of Pennsylvania | Peptides and peptidomimetics for inhibiting complement activation |
| PT1549333E (pt) | 2002-09-20 | 2012-01-03 | Univ Pennsylvania | Análogos de compstatina com actividade melhorada |
| EP2662089A3 (en) | 2005-10-08 | 2014-02-19 | Potentia Pharmaceuticals, Inc. | Compstatin and analogs thereof for eye disorders |
| CN102977191B (zh) | 2005-11-28 | 2016-08-10 | 宾夕法尼亚州大学理事会 | 有效的c3补体抑制素类似物 |
| WO2008153963A1 (en) | 2007-06-08 | 2008-12-18 | The Trustees Of The University Of Pennsylvania | Structure of compstatin-c3 complex and use for rational drug design |
| CA2813049A1 (en) * | 2010-09-23 | 2012-03-29 | The Trustees Of The University Of Pennsylvania | Modified compstatin with improved stability and binding properties |
| RU2606120C2 (ru) * | 2011-08-31 | 2017-01-10 | Хантсман Эдванст Матириалз (Свитзеленд) Гмбх | Способ пропитки реакторов с воздушным сердечником, подвергнутый пропитке реактор с воздушным сердечником и применение системы пропитки |
| CA2847862C (en) | 2011-09-07 | 2021-01-12 | The Trustees Of The University Of Pennsylvania | Compstatin analogs with improved pharmacokinetic properties |
| US9512180B2 (en) | 2012-12-19 | 2016-12-06 | The Regents Of The University Of California | Compstatin analogs |
| US10213476B2 (en) * | 2014-03-17 | 2019-02-26 | The Trustees Of The University Of Pennsylvania | Compstatin analogs with improved potency and pharmacokinetic properties |
| RU2020128624A (ru) * | 2018-02-27 | 2022-03-28 | Зп Спв 3 К/С | Аналоги компстатина и их медицинское применение |
| BR112022003760A2 (pt) * | 2019-08-27 | 2022-05-31 | Zp Spv 3 K/S | Análogos de compstatina e seus usos médicos |
-
2021
- 2021-07-15 IL IL299870A patent/IL299870A/en unknown
- 2021-07-15 WO PCT/EP2021/069798 patent/WO2022013374A1/en not_active Ceased
- 2021-07-15 JP JP2023502703A patent/JP2023538807A/ja active Pending
- 2021-07-15 US US18/016,490 patent/US20230287051A1/en active Pending
- 2021-07-15 MX MX2023000679A patent/MX2023000679A/es unknown
- 2021-07-15 EP EP21742144.5A patent/EP4182023A1/en active Pending
- 2021-07-15 KR KR1020237005557A patent/KR20230039718A/ko active Pending
- 2021-07-15 CN CN202180062742.5A patent/CN116209671A/zh active Pending
- 2021-07-15 CA CA3185730A patent/CA3185730A1/en active Pending
- 2021-07-15 AU AU2021309548A patent/AU2021309548A1/en active Pending
-
2023
- 2023-02-09 CO CONC2023/0001411A patent/CO2023001411A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538807A5 (https=) | ||
| JP7819087B2 (ja) | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 | |
| TWI882061B (zh) | 介白素-23受體之肽抑制劑及其治療發炎性疾病之用途 | |
| ES2391974T3 (es) | Procedimientos y composiciones para el tratamiento de trastornos gastrointestinales | |
| CN101687006B (zh) | 具有改善特性的重建表面活性剂 | |
| ES2870914T3 (es) | Péptidos intestinales vasoactivos modificados | |
| JP2020073481A5 (https=) | ||
| CA3188410A1 (en) | Conjugated hepcidin mimetics | |
| TWI388333B (zh) | 具有改良性質之重組表面張力素 | |
| AU3279300A (en) | Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant | |
| JP2016501204A5 (https=) | ||
| JP2012067100A (ja) | Ｉｌ−２１の誘導体 | |
| JP2014516037A5 (https=) | ||
| TW202317604A (zh) | 用於治療遺傳性血鐵沉積症之鐵調素模擬物 | |
| TW201102083A (en) | Improved reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C) | |
| CN103946233A (zh) | 多黏菌素衍生物 | |
| RU2020128624A (ru) | Аналоги компстатина и их медицинское применение | |
| WO2018128828A1 (en) | Novel hepcidin mimetics and uses thereof | |
| JP2022545916A5 (https=) | ||
| CN103459419B (zh) | 具有抗炎活性的基于人乳铁蛋白的肽 | |
| TW202140073A (zh) | 玻尿酸衍生物、醫藥組合物及玻尿酸衍生物－藥物結合體 | |
| JP6998878B2 (ja) | 環状ポリペプチド、それらを得る方法、及びその治療的使用 | |
| JP2022535555A (ja) | Ｇｌｐ１／２二重アゴニストの非経口医薬組成物 | |
| JP2018531284A6 (ja) | 環状ポリペプチド、それらを得る方法、及びその治療的使用 | |
| CN114599389A (zh) | 变体fc结构域及其用途 |